Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Incyte
Company Monitoring Page for Incyte
latest headlines for company on cafepharma
Incyte study could bring lessons for cancer immunotherapy
Biopharma Dive
Wed, 03/14/18 - 11:27 am
Tags:
Incyte
,
cancer immunotherapy
,
metastatic melanoma
,
Merck
,
Keytruda
Concert rethinks R&D plans after loss in Incyte patent case
Fierce Biotech
Fri, 01/12/18 - 06:40 pm
Tags:
Concert Pharmaceuticals
,
Incyte
,
patents
,
R&D
,
CTP-543
JPM18: Incyte and Syros to collaborate in cancer R&D
Biopharma Dive
Wed, 01/10/18 - 06:57 pm
Tags:
Incyte
,
Syros Pharmaceuticals
,
cancer
,
R&D
,
JPMHC 2018
5 Biggest New Drugs of 2018
Motley Fool
Sun, 01/7/18 - 12:35 pm
Tags:
Gilead Sciences
,
Bictegravir/F/TAF
,
Novo Nordisk
,
semaglutide
,
Ozempic
,
Incyte
,
epacadostat
,
AbbVie
,
Rova-T
,
Celgene
,
ozanimod
Why These 3 Biotech Stocks Could Outperform Their Peers In 2018
Investors Business Daily
Sat, 01/6/18 - 12:32 pm
Tags:
biotech
,
Puma Biotechnology
,
Incyte
,
Clovis Oncology
3 Promising Cancer Immunotherapies to Watch in 2018
Yahoo/Motley Fool
Fri, 12/22/17 - 09:46 am
Tags:
cancer
,
immuno-oncology
,
Incyte
,
epacadostat
,
Bristol-Myers Squibb
,
relatlimab
,
Nektar
,
NKTR-214
The top 10 prospective blockbuster drug launches slated for 2018 — Evaluate
Endpoints
Sun, 12/17/17 - 11:47 am
Tags:
drug launches
,
Bictegravir/F/TAF
,
Gilead Sciences
,
semaglutide
,
Novo Nordisk
,
epacadostat
,
Incyte
,
Rova-T
,
AbbVie
,
ozanimod
,
Celgene
,
apalutamide
,
JNJ
,
Elagolix
,
AVXS-101
,
AveXis
,
lanadelumab
,
Shire
,
Epidiolex
,
GW Pharma
8 Takeout targets to watch in 2018
BioPharma Dive
Sat, 12/16/17 - 08:41 am
Tags:
M&A
,
Allergan
,
Alnylam
,
Biomarin
,
Bristol-Myers Squibb
,
Incyte
,
Madrigal Pharmaceuticals
,
Spark Therapeutics
,
Sucampo
Bristol-Myers offers a positive snapshot on early data for an IDO1 rival to Incyte
Endpoints
Fri, 11/10/17 - 11:35 am
Tags:
Bristol-Myers Squibb
,
IDO1
,
BMS-986205
,
Incyte
,
bladder cancer
,
cervical cancer
AstraZeneca plans new pivotal lung cancer trial with Incyte
Yahoo/Reuters
Tue, 10/31/17 - 10:04 am
Tags:
AstraZeneca
,
Incyte
,
clinical trials
,
Imfinzi
,
epacadostat
,
lung cancer
Incyte grabs a new PD-1 checkpoint drug in $900M deal with MacroGenics
Endpoints
Wed, 10/25/17 - 09:44 am
Tags:
Incyte
,
PD-1 inhibitors
,
Macrogenics
,
MGA012
That $1.25B Bristol-Myers IDO1 drug? Incyte claims a former staffer stole it
Endpoints
Sun, 10/15/17 - 01:16 pm
Tags:
Bristol-Myers Squibb
,
IDO1
,
Incyte
,
Flexus
Biotech Firm Incyte Finds The Right Chemistry For Success
Forbes
Tue, 10/10/17 - 10:25 am
Tags:
Incyte
,
biotech
,
Jakafi
3 Monster Biotech Stocks in the Making
Motley Fool
Sun, 09/24/17 - 10:24 am
Tags:
biotech
,
Exelixis
,
Incyte
,
Vertex Pharmaceuticals
Incyte’s good week continues with an encouraging update on IDO1 star epacadostat
Endpoints
Thu, 08/31/17 - 10:07 pm
Tags:
Incyte
,
IDO1
,
epacadostat
,
Keytruda
,
Merck
Incyte, Merck build case for skin cancer combo
BioPharma Dive
Thu, 08/31/17 - 11:42 am
Tags:
Incyte
,
Merck
,
Keytruda
,
advanced melanoma
3 Most Promising Cancer Drugs in Late-Stage Development
Motley Fool
Tue, 08/22/17 - 10:04 am
Tags:
Eli Lilly
,
abemaciclib
,
advanced breast cancer
,
Incyte
,
epacadostat
,
Imbruvica
,
JNJ
,
prostate cancer
The sector’s most valuable unpartnered assets – up for grabs or on the shelf?
EP Vantage
Tue, 08/22/17 - 09:55 am
Tags:
R&D
,
Kite Pharma
,
Incyte
,
Portola Pharmaceuticals
,
DBV Technologies
,
Axovant
,
AveXis
Tesaro's rumored buyers aren't biting. Should Gilead go for Incyte instead?
Fierce Pharma
Sat, 07/15/17 - 11:14 am
Tags:
Tesaro
,
Gilead Sciences
,
Incyte
,
M&A
Pining for a megadeal, an analyst kicks the tires for another Gilead M&A test drive
Endpoints
Fri, 07/14/17 - 11:28 am
Tags:
M&A
,
Gilead Sciences
,
Incyte
,
Vertex Pharmaceuticals
,
John Milligan
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
a dog would most likely chase a: cat, rock, house
*
Fill in the blank.